Fosun Pharma proposes restricted share scheme for employees

Shanghai Fosun Pharmaceutical proposed adopting a 2025 H Share RSU scheme, subject to shareholder approval. The board proposed granting 10,696,400 RSUs to 201 eligible employees, including 953,500 RSUs for executive director Mr. Chen and 762,800 for Mr. Liu.

Total RSUs under the scheme will not exceed 13,370,500, representing approximately 0.5% of shares in issue. The scheme runs for 60 months with vesting periods of 12, 24, and 36 months tied to performance targets.